Insider · CIK 0001741937

Davidson Matt

Reports to the SEC for 2 companies · GLEN ALLEN, VA

sec.gov

Transactions

Companies

Filings

CIK

0001741937

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Development Officer	AAward	+232K sh	—	—	297,491
2026-06-12	ADILADIAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director, Chief Development Officer	AAward	+232K sh	—	—	232,417
2026-06-11	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Development Officer	AAward	+101.298 sh	—	—	1,923.428
2026-06-11	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Development Officer	AAward	+1,822.13 sh	—	—	1,822.13
2026-06-11	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Development Officer	AAward	+3,427 sh	—	—	3,427
2026-06-11	ADILADIAL PHARMACEUTICALS, INC.A Award	Director, Chief Development Officer	AAward	+61.6K sh	—	—	61,647
2019-09-09	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−6,300 sh	$10.82	−$68.2K	2,556,179
2019-09-06	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,400 sh	$12.07	−$16.9K	2,562,479
2019-09-06	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,802 sh	$10.38	−$39.5K	2,568,591
2019-09-06	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−4,712 sh	$11.44	−$53.9K	2,563,879
2019-09-05	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,100 sh	$10.29	−$31.9K	2,572,393
2019-08-29	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,188 sh	$10.14	−$22.2K	2,575,493
2019-08-27	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−500 sh	$10.23	−$5,115	2,577,681
2019-08-09	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,773 sh	$10.21	−$28.3K	2,578,181
2019-08-08	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,118 sh	$10.76	−$33.5K	2,580,954
2019-08-07	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−422 sh	$10.28	−$4,338.16	2,584,072
2019-08-06	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,602 sh	$10.28	−$26.7K	2,584,494
2019-08-05	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,679 sh	$10.65	−$17.9K	2,587,096
2019-08-02	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,969 sh	$10.78	−$21.2K	2,588,775
2019-08-01	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,953 sh	$11.97	−$23.4K	2,590,744
2019-07-31	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,500 sh	$12.02	−$42.1K	2,592,697
2019-07-30	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−4,885 sh	$11.83	−$57.8K	2,596,197
2019-07-29	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−630 sh	$12.52	−$7,887.6	2,601,082
2019-07-29	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−8,551 sh	$11.62	−$99.4K	2,601,712
2019-07-26	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,902 sh	$10.65	−$20.3K	2,610,263
2019-07-25	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−975 sh	$10.23	−$9,974.25	2,612,165
2019-07-24	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−502 sh	$10.19	−$5,115.38	2,613,140
2019-07-23	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,600 sh	$10.28	−$16.4K	2,613,642
2019-07-22	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−700 sh	$10.17	−$7,119	2,615,242
2019-07-19	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,800 sh	$10.28	−$18.5K	2,615,942
2019-07-18	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−6,700 sh	$10.27	−$68.8K	2,617,742
2019-07-17	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,300 sh	$10.55	−$24.3K	2,624,442
2019-07-16	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,200 sh	$10.92	−$24K	2,626,742
2019-07-15	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−5,290 sh	$10.89	−$57.6K	2,628,942
2019-07-12	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,000 sh	$11.01	−$33K	2,634,232
2019-07-11	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,640 sh	$11.16	−$18.3K	2,637,232
2019-07-10	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−9,105 sh	$11.57	−$105K	2,638,872
2019-07-09	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,467 sh	$11.88	−$29.3K	2,647,977
2019-07-08	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−5,675 sh	$11.06	−$62.8K	2,650,444
2019-07-05	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,954 sh	$11.41	−$45.1K	2,656,119
2019-07-03	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,900 sh	$11.50	−$33.4K	2,660,073
2019-07-02	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−6,239 sh	$11.57	−$72.2K	2,662,973
2019-07-01	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−15.4K sh	$12.00	−$185K	2,669,212
2019-06-28	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−8,359 sh	$11.41	−$95.4K	2,684,633
2019-06-28	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−3,502 sh	$10.63	−$37.2K	2,692,992
2019-06-25	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−210 sh	$10.04	−$2,108.4	2,696,494
2019-06-13	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−1,431 sh	$10.03	−$14.4K	2,696,704
2019-06-12	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−700 sh	$8.86	−$6,202	2,698,135
2019-06-11	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−838 sh	$8.89	−$7,449.82	2,698,835
2019-06-10	VRCAVerrica Pharmaceuticals Inc.S Sale	10% Owner	SSale	−2,100 sh	$8.79	−$18.5K	2,699,673

Recent filings

Accepted (ET)
Jun 164
Davidson Matt0001213900-26-069037
SEC(opens sec.gov)
Sep 94
Davidson Matt0001209191-19-048940
SEC(opens sec.gov)
Aug 294
Davidson Matt0001209191-19-047734
SEC(opens sec.gov)
Aug 94
Davidson Matt0001209191-19-045382
SEC(opens sec.gov)
Aug 64
Davidson Matt0001209191-19-044881
SEC(opens sec.gov)
Aug 14
Davidson Matt0001209191-19-044073
SEC(opens sec.gov)

Companies

Address

C/O ADIAL PHARMACEUTICALS, INC. 4870 SADLER ROAD, SUITE 300

GLEN ALLEN, VA, 23060